Luts & Greenleigh Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $373K | Buy |
4,708
+171
| +4% | +$13.5K | 0.36% | 52 |
|
2025
Q1 | $407K | Sell |
4,537
-327
| -7% | -$29.4K | 0.4% | 48 |
|
2024
Q4 | $484K | Buy |
4,864
+421
| +9% | +$41.9K | 0.48% | 43 |
|
2024
Q3 | $504K | Sell |
4,443
-41
| -0.9% | -$4.66K | 0.48% | 43 |
|
2024
Q2 | $555K | Buy |
+4,484
| New | +$555K | 0.58% | 35 |
|
2023
Q4 | $597K | Buy |
5,472
+40
| +0.7% | +$4.36K | 0.75% | 29 |
|
2023
Q3 | $559K | Sell |
5,432
-194
| -3% | -$20K | 0.69% | 31 |
|
2023
Q2 | $649K | Buy |
5,626
+152
| +3% | +$17.5K | 0.8% | 30 |
|
2023
Q1 | $582K | Buy |
5,474
+47
| +0.9% | +$5K | 0.74% | 28 |
|
2022
Q4 | $602K | Buy |
+5,427
| New | +$602K | 0.76% | 25 |
|